Reinstatement to Official Quotation
Filed with ASX · · 1 page · English
Summary by 6ix AI
Cynata Therapeutics Limited has announced its reinstatement to official quotation on the Australian Stock Exchange.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Cynata Therapeutics Limited on 6ix
Earlier from Cynata Therapeutics
- CYP-001 GvHD Trial Primary Evaluation Results
- Suspension from Quotation
- EU Positive Opinion on CYP-001 Paediatric Investigation Plan
- Cynata Secures Commitments for $1.5m Placement
- March 2026 Quarterly Activity Report & Appendix 4C
Later from Cynata Therapeutics
- Board, Management Changes, Expenditure Reductions, RDTI Loan
- June 2026 Quarterly Activity Report & Appendix 4C
- Appendix 4E & Preliminary Final Report
- Notification under Listing Rule 4.3D
- R&D Tax Incentive Loan Facility Extension
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics